Emily’s Entourage speeds lifesaving research and drug development for individuals in the final 10% of the cystic fibrosis (CF) community that do not benefit from currently available mutation-targeted therapies.
I SUSSIDI CHE FINANZIAMO
EE ha assegnato milioni di dollari a gruppi multidisciplinari in tutto il mondo per far progredire la ricerca e lo sviluppo di farmaci per il 10% finale delle persone affette da FC.
On October 11, 2025, join us for the 2025 Evening with Emily’s Entourage gala as we step into a new era—one defined by clarity, precision, and fast progress for the final 10% of the cystic fibrosis community. The future is coming into focus.
Emily’s Entourage CF Clinical Trial Connect (CTC) is the only global patient database exclusively for people with CF who are unable to benefit from CFTR modulators. By joining, you can help accelerate the development of new, lifesaving CF therapies.
Emily’s Entourage is proud to announce that it has awarded a one-year research grant to Jeffrey Beekman, PhD, at the University Medical Center, Utrecht, Netherlands.... Per saperne di più
Last week was Rare Disease Week, a special opportunity to raise critical awareness for rare disease. A disease is considered rare when it affects fewer... Per saperne di più
Our #FallinLovEE with EE Series continues this month, this time with longtime EE friend, volunteer, and go-to gal, Sarena Snider. As Sarena recounts how she... Per saperne di più
From time to time we invite guest bloggers who are part of the EE community to contribute their unique voices to our blog. Today’s guest... Per saperne di più
Utilizzeremo queste informazioni per inviarvi notizie e aggiornamenti su Emily's Entourage e per offrirvi la possibilità di sostenere la nostra ricerca.